Author: Marta Trojniak
Compare how the “do’s and don’ts” of hazardous drug handling differ across Europe and discover how international directives could impact your working practice with this module. Watch Marta Trojniak introduce her updated module.
Key Paper Evaluation
Updates to directive 2004/37/EC of the European Parliament and European Council were appoved on 8 March 2022. This 2-pager summarises the updates which are set to be released this year.
This short editorial summarises the definitions of closed systems versus closed system drug transfer devices.
Interactive guide to the guidelines
This interactive pathway maps the key guidelines onto the various points of potential hazardous drug contamination in the hospital.
Engineering controls such as closed systems and CSTDs are essential for safe handling of hazardous drugs. This infographic illustrates the differences between closed systems and CSTDs.
Key Paper Evaluation
This one-pager summarises key information from three important documents for engineering controls: a joint position statement from the Oncology Nursing Society and the Hematology/Oncology Pharmacy Assocation, the USP <800>, and the NIOSH Hierarchy of Controls
Authors: Alison Simons and Samantha Toland
The use of hazardous drugs (HD) for example cytotoxic drugs to treat cancer, has increased exponentially over the last 40 years. Sadly, however the awareness of the risks in administering HD has not increased at the same rate. Hear what two nurses have to say about the role of nurses in the handling of these drugs and what controls can be put in place to help mitigate the risks.
Hazardous drug handling is a complex, interdisciplinary process that requires adherance to guidelines and recommendations. This editorial dicsusses the scope of some of the various available guidelines and the importance of keeping up to date with their changes.
Author: Johan Vandenbroucke
All healthcare professionals, and especially hospital pharmacists, need to concern themselves with ensuring the quality of injectable medications. This module explores the technologies used to maintain product integrity from preparation to administration. Watch Johan Vandenbrouke briefly introduce his updated module.
Author: Dr Nicolas Simon
Dr Nicolas Simon introduces his updated module which delves into the problem of decontaminating antineoplastic drug compounding facilities.